Gio Gonzalez was named in the Biogenesis report. Then, reports James Wagner:
Gonzalez had blood and urine samples taken two days after the New Times report was published on Jan. 29, according to two people with knowledge of the situation.
Baseball is allowed to do “reasonable cause” testing. The Joint Drug Agreement says that can happen with two days’ notice. Don’t gotta be a rocket scientist to figure this one out.
In the event that there was a positive test it would be weeks or even a month or two before it was known.
Kristie Ackert of the New York Daily News reports that the Mets have discussed a trade involving starter Matt Harvey with at least two teams. Apparently, the Mets were even willing to move Harvey for a reliever.
The Mets tendered Harvey a contract on December 1. He’s entering his third and final year of arbitration eligibility and will likely see a slight bump from last season’s salary of $5.125 million. As a result, there was some thought going into late November that the Mets would non-tender Harvey.
Harvey, 28, made 18 starts and one relief appearance last year and had horrendous results. He put up a 6.70 ERA with a 67/47 K/BB ratio in 92 2/3 innings. Between his performance, his impending free agency, and his injury history, the Mets aren’t likely to get much back in return for Harvey. Even expecting a reliever in return may be too lofty.
Along with bullpen help, the Mets also need help at second base, first base, and the outfield. They don’t have many resources with which to address those needs. Ackert described the Mets’ resources as “a very limited stash of prospects” and “limited payroll space.”